• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.

作者信息

Doweyko A M

机构信息

Uniroyal Chemical Co., Inc., Middlebury, Connecticut 06749.

出版信息

J Med Chem. 1988 Jul;31(7):1396-406. doi: 10.1021/jm00402a025.

DOI:10.1021/jm00402a025
PMID:3290487
Abstract

Microcomputer-assisted methods are described that allow the mathematical construction of a hypothetical active site lattice (HASL) which can model enzyme-inhibitor interactions and provides predictive structure-activity relationships for a set of competitive inhibitors. The inhibitor set can be structurally dissimilar, including acyclic and cyclic moieties normally refractory to classical parameter-based quantitative structure-activity relationship strategies. With use of three-dimensional Cartesian coordinates representing energy-minimized inhibitor conformations, a four-dimensional space-filling description is generated, wherein the fourth dimension can be a user-selected physiochemical property such as hydrophobicity or electron density. The multidimensional lattices thus generated are used to quantitatively compare molecules to one another. Composite lattices of more than one molecule are merged with binding data to form a HASL capable of predicting inhibitor binding and relative orientation. Details of the algorithms and assumptions utilized are illustrated for competitive inhibitors of yeast glyoxalase-I and E. coli dihydrofolate reductase.

摘要

相似文献

1
The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.
J Med Chem. 1988 Jul;31(7):1396-406. doi: 10.1021/jm00402a025.
2
Investigation on glyoxalase I inhibitors.
Biochem Biophys Res Commun. 1989 Nov 30;165(1):118-24. doi: 10.1016/0006-291x(89)91042-5.
3
Binding of the competitive inhibitor S-(p-bromobenzyl)-glutathione to glyoxalase I from yeast.竞争性抑制剂S-(对溴苄基)-谷胱甘肽与酵母乙二醛酶I的结合。
FEBS Lett. 1979 Jun 1;102(1):162-4. doi: 10.1016/0014-5793(79)80950-3.
4
Partial transition-state inhibitors of glyoxalase I from human erythrocytes, yeast and rat liver.
Biochim Biophys Acta. 1985 May 20;829(1):109-18. doi: 10.1016/0167-4838(85)90074-3.
5
QSAR of the inhibition of glyoxalase by S-substituted glutathiones.S-取代谷胱甘肽对乙二醛酶抑制作用的定量构效关系
Farmaco Sci. 1979 Jan;34(1):3-10.
6
Nonadditivity of mutational effects at the folate binding site of Escherichia coli dihydrofolate reductase.大肠杆菌二氢叶酸还原酶叶酸结合位点突变效应的非加和性
Biochemistry. 1994 Sep 27;33(38):11576-85. doi: 10.1021/bi00204a020.
7
The structure of a glyoxalase I inhibitor and its chemical reactivity with SH-compounds.
J Antibiot (Tokyo). 1975 Oct;28(10):743-8. doi: 10.7164/antibiotics.28.743.
8
A glyoxalase I inhibitor of a new structural type produced by Streptomyces.
J Antibiot (Tokyo). 1975 Oct;28(10):737-42. doi: 10.7164/antibiotics.28.737.
9
Synthesis and kinetic evaluation of S- and N-substituted cysteinylglycines as inhibitors of glyoxalase I.S-和N-取代的半胱氨酰甘氨酸作为乙二醛酶I抑制剂的合成及动力学评估
J Med Chem. 1977 Jan;20(1):77-88. doi: 10.1021/jm00211a015.
10
Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors.基于距离几何的定量构效关系:二氢叶酸还原酶抑制剂的系统分析
J Med Chem. 1980 Jun;23(6):599-606. doi: 10.1021/jm00180a004.

引用本文的文献

1
Clustering of atoms relative to vector space in the Z-matrix coordinate system and 'graphical fingerprint' analysis of 3D pharmacophore structure.Z矩阵坐标系中原子相对于向量空间的聚类以及三维药效团结构的“图形指纹”分析。
Mol Divers. 2024 Dec;28(6):4087-4104. doi: 10.1007/s11030-023-10798-1. Epub 2024 Jan 28.
2
Comparison of Different 2D and 3D-QSAR Methods on Activity Prediction of Histamine H3 Receptor Antagonists.不同二维和三维定量构效关系方法对组胺H3受体拮抗剂活性预测的比较
Iran J Pharm Res. 2012 Winter;11(1):97-108.
3
QSAR modeling: where have you been? Where are you going to?
定量构效关系模型:你从何处来?你将往何处去?
J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6.
4
A new paradigm for pattern recognition of drugs.药物模式识别的新范式。
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):489-505. doi: 10.1007/s10822-008-9203-x. Epub 2008 Mar 21.
5
Hierarchical QSAR technology based on the Simplex representation of molecular structure.基于分子结构单纯形表示法的分层定量构效关系技术。
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):403-21. doi: 10.1007/s10822-008-9179-6. Epub 2008 Feb 6.
6
A comprehensive analysis of the thermodynamic events involved in ligand-receptor binding using CoRIA and its variants.使用CoRIA及其变体对配体-受体结合所涉及的热力学事件进行全面分析。
J Comput Aided Mol Des. 2008 Feb;22(2):91-104. doi: 10.1007/s10822-008-9172-0. Epub 2008 Jan 25.
7
Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands.比较残基相互作用分析(CoRIA):一种用于探索活性位点残基与配体结合贡献的3D-QSAR方法。
J Comput Aided Mol Des. 2006 Jun;20(6):343-60. doi: 10.1007/s10822-006-9051-5. Epub 2006 Sep 29.
8
Hierarchic system of QSAR models (1D-4D) on the base of simplex representation of molecular structure.基于分子结构单纯形表示的QSAR模型(1D - 4D)层次系统。
J Mol Model. 2005 Nov;11(6):457-67. doi: 10.1007/s00894-005-0237-x. Epub 2005 Oct 20.
9
3D-QSAR illusions.三维定量构效关系假象
J Comput Aided Mol Des. 2004 Jul-Sep;18(7-9):587-96. doi: 10.1007/s10822-004-4068-0.
10
3D-QSAR using 'multiconformer' alignment: the use of HASL in the analysis of 5-HT1A thienopyrimidinone ligands.使用“多构象体”比对的3D-QSAR:HASL在5-羟色胺1A噻吩并嘧啶酮配体分析中的应用
J Comput Aided Mol Des. 2000 Oct;14(7):647-57. doi: 10.1023/a:1008136325544.